Inotiv Inc Stock Today
| NOTV Stock | USD 2.98 0.35 13.31% |
PerformanceVery Weak
| Odds Of DistressBelow Average
|
Inotiv is selling for under 2.98 as of the 17th of March 2025; that is 13.31 percent increase since the beginning of the trading day. The stock's lowest day price was 2.73. Inotiv has about a 38 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of November 1997 | Category Healthcare | Classification Health Care |
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana. The company has 33.87 M outstanding shares of which 1.94 M shares are now shorted by private and institutional investors with about 2.83 trading days to cover. More on Inotiv Inc
Moving together with Inotiv Stock
Moving against Inotiv Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Inotiv Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Robert Leasure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInotiv can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inotiv's financial leverage. It provides some insight into what part of Inotiv's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inotiv Inc (NOTV) is traded on NASDAQ Exchange in USA. It is located in 2701 Kent Avenue, West Lafayette, IN, United States, 47906 and employs 1,977 people. Inotiv is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 100.93 M. Inotiv Inc conducts business under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 33.87 M outstanding shares of which 1.94 M shares are now shorted by private and institutional investors with about 2.83 trading days to cover.
Inotiv Inc currently holds about 21.24 M in cash with (6.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83.
Check Inotiv Probability Of Bankruptcy
Ownership AllocationInotiv Inc has a total of 33.87 Million outstanding shares. Inotiv retains 11.14 (percent) of its outstanding shares held by insiders and 26.64 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Inotiv Ownership Details
Inotiv Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Blackrock Inc | 2024-12-31 | 212.8 K | |
| Marshall Wace Asset Management Ltd | 2022-12-31 | 177.9 K | |
| Fourworld Capital Management Llc | 2024-12-31 | 149.6 K | |
| Thurston Springer Miller Herd & Titak Inc | 2024-12-31 | 127.3 K | |
| Mariner Wealth Advisors Llc | 2024-12-31 | 121.8 K | |
| Perkins Capital Management Inc | 2024-12-31 | 120 K | |
| Bank Of New York Mellon Corp | 2024-12-31 | 116 K | |
| Nkcfo Llc | 2024-12-31 | 115 K | |
| Ameriprise Financial Inc | 99.3 K | ||
| Silverback Aset Management Llc | 2024-12-31 | 1.3 M | |
| Balyasny Asset Management Llc | 2024-12-31 | 1.3 M |
Inotiv Historical Income Statement
Inotiv Stock Against Markets
Inotiv Corporate Management
| Adrian Hardy | Executive Development | Profile | |
| Fernanda Beraldi | Gen Sec | Profile | |
| Mo Dastagir | Chief Officer | Profile | |
| Peter Kissinger | Chairman Founder | Profile | |
| Kimberly Beaty | Director Marketing | Profile | |
| William Pitchford | Chief Officer | Profile |
Additional Tools for Inotiv Stock Analysis
When running Inotiv's price analysis, check to measure Inotiv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inotiv is operating at the current time. Most of Inotiv's value examination focuses on studying past and present price action to predict the probability of Inotiv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inotiv's price. Additionally, you may evaluate how the addition of Inotiv to your portfolios can decrease your overall portfolio volatility.